Institutional Ownership
Tg Therapeutics Inc
CUSIP 88322Q108COMTGTXQ1 2026
13D / 13G Filings
35
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
14.5%
Max % of class reported
Institutional Holders
354
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
35 filings · latest Nov 10, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 10, 2025 | State Street Corporation | 13G | 5.1% | 8.10M | SEC |
| 2 | May 13, 2025 | State Street Corporation | 13G | 4.7% | 7.43M | SEC |
| 3 | Apr 30, 2025 | Blackrock, Inc. | 13G/A | 12.8% | 20.13M | SEC |
| 4 | Jan 8, 2025 | The Vanguard Group | 13G/A | 10.0% | 15.60M | SEC |
| 5 | Nov 14, 2024 | Darwin Global Management, Ltd. | 13G/A | — | — | SEC |
| 6 | Oct 7, 2024 | Blackrock, Inc. | 13G/A | 14.2% | 21.96M | SEC |
| 7 | Feb 14, 2024 | Darwin Global Management, Ltd. | 13G/A | 2.7% | 4.05M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.0% | 13.67M | SEC |
| 9 | Jan 26, 2024 | Blackrock Inc. | 13G/A | 7.1% | 10.77M | SEC |
| 10 | Jan 25, 2024 | State Street Corp | 13G/A | 5.5% | — | SEC |
25 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tg Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 22.25M | $739.24M |
| 2 | State Street Corp | 8.65M | $287.35M |
| 3 | Soleus Capital Management, L.P. | 4.03M | $133.85M |
| 4 | Geode Capital Management, LLC | 3.50M | $116.29M |
| 5 | Clearbridge Investments, LLC | 3.21M | $106.67M |
| 6 | Goldman Sachs Group Inc | 2.29M | $76.00M |
| 7 | Congress Asset Management Co | 2.17M | $72.02M |
| 8 | Jane Street Group, LLC | 2.04M | $67.82M |
| 9 | Citadel Advisors LLC | 1.92M | $63.88M |
| 10 | Pictet Asset Management Holding SA | 1.75M | $58.05M |